Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlorophytum borivilianum
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Chlorophytum borivilianum is a herbaceous plant native to India, widely known as safed musli. Its tuberous roots are used in traditional medicine, especially in Ayurveda, primarily as a health tonic, adaptogen, and revitalizer. The herb is traditionally recognized for its aphrodisiac, immunomodulatory, antidiabetic, and anti-inflammatory effects. Root extracts are rich in saponins, alkaloids, polysaccharides, and antioxidant compounds. It is commonly used to improve sexual dysfunction, diabetes management, infections, and general health. While used extensively in dietary supplements, robust clinical evidence for therapeutic human use is limited.
- Other names
- chlorophytum borivilianumsafed muslishweta musliswetha muslitella nela taditaniravi thangkhairuwa
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on chlorophytum borivilianum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlorophytum borivilianum.